{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:14:48Z","timestamp":1787606088547,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10147-022-02253-2","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T18:02:41Z","timestamp":1665597761000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0754-5682","authenticated-orcid":false,"given":"Tzu-Rong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsien","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"crossref","unstructured":"Pham CQ, Regal RE, Bostwick TR, et al. (2006) Acid suppressive therapy use on an inpatient internal medicine service, Ann Pharmacother 40: 1261e6.","DOI":"10.1345\/aph.1G703"},{"issue":"2","key":"2253_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3390\/jcm8020179","volume":"8","author":"L Kuna","year":"2019","unstructured":"Kuna L, Jakab J, Smolic R et al (2019) Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. J Clin Med 8(2):179","journal-title":"J Clin Med"},{"issue":"24","key":"2253_CR3","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1001\/jama.2020.21360","volume":"324","author":"J Maret-Ouda","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J (2020) Gastroesophageal reflux disease: a review. JAMA 324(24):2536\u20132547","journal-title":"JAMA"},{"issue":"2","key":"2253_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/17474124.2021.1826306","volume":"15","author":"J Yun","year":"2021","unstructured":"Yun J, Wu Z, Qi G et al (2021) The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication of Helicobacter pylori infection. Expert Rev Gastroenterol Hepatol 15(2):149\u2013157","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2253_CR5","first-page":"354","volume":"63","author":"B Farrell","year":"2017","unstructured":"Farrell B, Pottie K, Thompson W et al (2017) Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician 63:354\u2013364","journal-title":"Can Fam Physician"},{"key":"2253_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2253_CR7","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00228-020-02927-8","volume":"76","author":"HJ Song","year":"2020","unstructured":"Song HJ, Jeon N, Squires P (2020) The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis. Eur J Clin Pharmacol 76(10):1437\u20131456","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2253_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/gutjnl-2018-316416","volume":"68","author":"QY Wan","year":"2019","unstructured":"Wan QY, Wu XT, Li N et al (2019) Long-term proton pump inhibitors use and risk of gastric cancer: a meta-analysis of 926386 participants. Gut 68(4):762\u2013764","journal-title":"Gut"},{"issue":"1","key":"2253_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/gutjnl-2021-325097","volume":"71","author":"D Abrahami","year":"2022","unstructured":"Abrahami D, McDonald EG, Schnitzer ME et al (2022) Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut 71(1):16\u201324","journal-title":"Gut"},{"issue":"11","key":"2253_CR10","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1136\/gutjnl-2020-323845","volume":"70","author":"SI Seo","year":"2021","unstructured":"Seo SI, Park CH, You SC et al (2021) Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 70(11):2066\u20132075","journal-title":"Gut"},{"issue":"6","key":"2253_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.14309\/ajg.0000000000001167","volume":"116","author":"GY Shin","year":"2021","unstructured":"Shin GY, Park JM, Hong J et al (2021) Use of proton pump inhibitors vs Histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study. Am J Gastroenterol 116(6):1211\u20131219","journal-title":"Am J Gastroenterol"},{"key":"2253_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"2253_CR13","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. (editors) (2021)\u00a0Cochrane Handbook for Systematic Reviews of Interventions\u00a0version 6.2\u00a0(updated February\u00a02021). Cochrane, available at https:\/\/www.training.cochrane.org\/handbook."},{"key":"2253_CR14","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses, available at http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"2253_CR15","doi-asserted-by":"crossref","unstructured":"Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 130.","DOI":"10.1093\/oxfordjournals.epirev.a036298"},{"key":"2253_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f7450","volume":"348","author":"RL Grant","year":"2014","unstructured":"Grant RL (2014) Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ 348:f7450","journal-title":"BMJ"},{"key":"2253_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d671","volume":"342","author":"PE Ronksley","year":"2011","unstructured":"Ronksley PE, Brien SE, Turner BJ et al (2011) Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 342:d671","journal-title":"BMJ"},{"issue":"3","key":"2253_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"key":"2253_CR19","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2005.086579","volume":"55","author":"LA Garc\u00eda Rodr\u00edguez","year":"2006","unstructured":"Garc\u00eda Rodr\u00edguez LA, Lagergren J, Lindblad M (2006) Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 55:1538\u20131544","journal-title":"Gut"},{"key":"2253_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2165\/00002018-200831080-00004","volume":"31","author":"H Tamim","year":"2008","unstructured":"Tamim H, Duranceau A, Chen LQ et al (2008) Association between use of acid-suppressive drugs and risk of gastric cancer. Drug Saf 31:675\u2013684","journal-title":"Drug Saf"},{"key":"2253_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","volume":"100","author":"AH Poulsen","year":"2009","unstructured":"Poulsen AH, Christensen S, McLaughlin JK et al (2009) Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer 100:1503\u20131507","journal-title":"Br J Cancer"},{"key":"2253_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017739","volume":"7","author":"N Brusselaers","year":"2017","unstructured":"Brusselaers N, Wahlin K, Engstrand L et al (2017) Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open 7:e017739","journal-title":"BMJ Open"},{"key":"2253_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.101585","volume":"62","author":"N Brusselaers","year":"2019","unstructured":"Brusselaers N, Lagergren J, Engstrand L (2019) Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiol 62:101585","journal-title":"Cancer Epidemiol"},{"key":"2253_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","volume":"67","author":"KS Cheung","year":"2018","unstructured":"Cheung KS, Chan EW, Wong AYS et al (2018) Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut 67:28\u201335","journal-title":"Gut"},{"key":"2253_CR25","first-page":"22","volume":"22","author":"R Niikura","year":"2017","unstructured":"Niikura R, Hayakawa Y, Hirata Y et al (2017) Long term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis. Gut 22:22","journal-title":"Gut"},{"key":"2253_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/gutjnl-2018-316371","volume":"68","author":"SW Lai","year":"2019","unstructured":"Lai SW, Lai HC, Lin CL et al (2019) Proton pump inhibitors and risk of gastric cancer in a case control study. Gut 68:765\u2013767","journal-title":"Gut"},{"key":"2253_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/gutjnl-2018-316057","volume":"68","author":"YC Peng","year":"2019","unstructured":"Peng YC, Huang LR, Lin CL et al (2019) Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD. Gut 68:374\u2013376","journal-title":"Gut"},{"key":"2253_CR28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/ijc.29896","volume":"138","author":"LN Chien","year":"2016","unstructured":"Chien LN, Huang YJ, Shao YH et al (2016) Proton pump inhibitors and risk of periampullary cancers: a nested case-control study. Int J Cancer 138:1401\u20131409","journal-title":"Int J Cancer"},{"key":"2253_CR29","doi-asserted-by":"publisher","first-page":"706","DOI":"10.14309\/ajg.0000000000000591","volume":"115","author":"JK Lee","year":"2020","unstructured":"Lee JK, Merchant SA, Schneider JL et al (2020) Proton pump inhibitor use and risk of gastric, colorectal, liver, and pancreatic cancers in a community based population. Am J Gastroenterol 115:706\u2013715","journal-title":"Am J Gastroenterol"},{"key":"2253_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41416-020-0860-4","volume":"123","author":"P Liu","year":"2020","unstructured":"Liu P, McMenamin \u00daC, Johnston BT et al (2020) Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies. Br J Cancer 123:307\u2013315","journal-title":"Br J Cancer"},{"issue":"2","key":"2253_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/1055-9965.EPI-08-0764","volume":"18","author":"L Duan","year":"2009","unstructured":"Duan L, Wu AH, Sullivan-Halley J et al (2009) Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 18(2):526\u2013533","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2253_CR32","doi-asserted-by":"publisher","first-page":"175628482110514","DOI":"10.1177\/17562848211051463","volume":"14","author":"D Segna","year":"2021","unstructured":"Segna D, Brusselaers N, Glaus D et al (2021) Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis. Therap Adv Gastroenterol 14:17562848211051464","journal-title":"Therap Adv Gastroenterol"},{"key":"2253_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000199381","volume":"35","author":"N Havu","year":"1986","unstructured":"Havu N (1986) Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35:42\u201355","journal-title":"Digestion"},{"key":"2253_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1046\/j.1365-2036.1998.00349.x","volume":"12","author":"BE Schenk","year":"1998","unstructured":"Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al (1998) Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther 12:605\u2013612","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"2253_CR35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamapediatrics.2014.696","volume":"168","author":"R Rosen","year":"2014","unstructured":"Rosen R, Amirault J, Liu H et al (2014) Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth. JAMA Pediatr 168(10):932\u2013937","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2253_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS (2019) Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 16(4):235\u2013246","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"2253_CR37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/MEG.0000000000001198","volume":"30","author":"MM Islam","year":"2018","unstructured":"Islam MM, Poly TN, Walther BA et al (2018) Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 30(12):1395\u20131405","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"2253_CR38","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.cgh.2016.05.018","volume":"14","author":"A Tran-Duy","year":"2016","unstructured":"Tran-Duy A, Spaetgens B, Hoes AW et al (2016) Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol 14(12):1706-1719.e5","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2253_CR39","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/jgh.14759","volume":"34","author":"K Jiang","year":"2019","unstructured":"Jiang K, Jiang X, Wen Y et al (2019) Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: a systematic analysis. J Gastroenterol Hepatol 34(11):1898\u20131905","journal-title":"J Gastroenterol Hepatol"},{"key":"2253_CR40","doi-asserted-by":"crossref","unstructured":"Song H, Zhu J, Lu D (2014) Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev 12: CD010623.","DOI":"10.1002\/14651858.CD010623.pub2"},{"issue":"6","key":"2253_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/apt.13324","volume":"42","author":"L Lundell","year":"2015","unstructured":"Lundell L, Vieth M, Gibson F et al (2015) Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther 42(6):649\u2013663","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2253_CR42","first-page":"295","volume":"58","author":"HILL Ab","year":"1965","unstructured":"Ab HILL (1965) The environment and disease: association or causation. Proc R Soc Med 58(5):295\u2013300","journal-title":"Proc R Soc Med"},{"key":"2253_CR43","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1046\/j.1365-2036.2001.01029.x","volume":"15","author":"S Sanduleanu","year":"2001","unstructured":"Sanduleanu S, Jonkers D, De Bruine A et al (2001) Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of proinflammatory cytokines and development of atrophic gastritis. Aliment Pharmacol Ther 15:1163\u20131175","journal-title":"Aliment Pharmacol Ther"},{"key":"2253_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3867","volume":"351","author":"H Song","year":"2015","unstructured":"Song H, Ekheden IG, Zheng Z et al (2015) Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 351:h3867","journal-title":"BMJ"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02253-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02253-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:24:40Z","timestamp":1672989880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02253-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02253-2","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"7 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}